Cited by 273

The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

Open access

Kaufmann, Stefan H E, McMichael, Andrew J·2005·Nature Medicine

Open this paper in CoChat — free account

Abstract

Human immunodeficiency virus (HIV) and Mycobacterium tuberculosis annually cause 3 million and 2 million deaths, respectively. Last year, 600,000 individuals, doubly infected with HIV and M. tuberculosis, died. Since World War I, approximately 150 million people have succumbed to these two infections—more total deaths than in all wars in the last 2,000 years. Although the perceived threats of new infections such as SARS, new variant Creutzfeldt-Jakob disease and anthrax are real, these outbreaks have caused less than 1,000 deaths globally, a death toll AIDS and tuberculosis exact every 2 h. In 2003, 40 million people were infected with HIV, 2 billion with M. tuberculosis, and 15 million with both. Last year, 5 million and 50 million were newly infected with HIV or M. tuberculosis, respectively, with 2 million new double infections. Better control measures are urgently needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nm1221

Cites

105 of 105 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Maini, R., St Clair, E. W., Breedveld, F., Furst, D., Kalden, J., Weisman, M., Smolen, J., Emery, P., Harriman, G., Feldmann, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05246-0 · Cited by 2,345
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Di Rosa, F., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,342
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.1994.03510330076038 · Cited by 1,918
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,832
Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray
Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S., & Small, P. M. (1999) · Science · doi:10.1126/science.284.5419.1520 · Cited by 1,542
Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory
Shedlock, D. J., & Shen, H. (2003) · Science · doi:10.1126/science.1082305 · Cited by 1,460
Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
McKinney, J. D., zu Bentrup, K. H., Muñoz-Elías, E. J., Miczak, A., Chen, B., Chan, W.-T., Swenson, D., Sacchettini, J. C., Jacobs, W. R., & Russell, D. G. (2000) · Nature · doi:10.1038/35021074 · Cited by 1,360
HIV preferentially infects HIV-specific CD4+ T cells
Douek, D. C., Brenchley, J. M., Betts, M. R., Ambrozak, D. R., Hill, B. J., Okamoto, Y., Casazza, J. P., Kuruppu, J., Kunstman, K., Wolinsky, S., et al. (2002) · Nature · doi:10.1038/417095a · Cited by 1,262
The antigenic structure of the HIV gp120 envelope glycoprotein
Wyatt, R., Kwong, P. D., Desjardins, E., Sweet, R. W., Robinson, J., Hendrickson, W. A., & Sodroski, J. G. (1998) · Nature · doi:10.1038/31514 · Cited by 1,203
Rapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
Shiver, J. W., Fu, T.-M., Chen, L., Casimiro, D. R., Davies, M.-E., Evans, R. K., Zhang, Z.-Q., Simon, A. J., Trigona, W. L., Dubey, S. A., et al. (2002) · Nature · doi:10.1038/415331a · Cited by 1,176
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
Amara, R. R. (2001) · Science · doi:10.1126/science.1058915 · Cited by 1,106
Timing the ancestor of the HIV-1 pandemic strains.
Korber, B., Muldoon, M., Theiler, J., Gao, F., Gupta, R., Lapedes, A., Hahn, B. H., Wolinsky, S., & Bhattacharya, T. (2000) · Science · doi:10.1126/science.288.5472.1789 · Cited by 1,021
Protective Effects of a Live Attenuated SIV Vaccine with a Deletion in the nef Gene
Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., & Desrosiers, R. C. (1992) · Science · doi:10.1126/science.1470917 · Cited by 1,015
Immune control of HIV-1 after early treatment of acute infection
Rosenberg, E. S., Altfeld, M., Poon, S. H., Phillips, M. N., Wilkes, B. M., Eldridge, R. L., Robbins, G. K., D'Aquila, R. T., Goulder, P. J. R., & Walker, B. D. (2000) · Nature · doi:10.1038/35035103 · Cited by 1,002
Genetic Dissection of Immunity to Mycobacteria: The Human Model
Casanova, J.-L., & Abel, L. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.081501.125851 · Cited by 991
Inhibition of Respiration by Nitric Oxide Induces a Mycobacterium tuberculosis Dormancy Program
Voskuil, M. I., Schnappinger, D., Visconti, K. C., Harrell, M. I., Dolganov, G. M., Sherman, D. R., & Schoolnik, G. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030205 · Cited by 966
Iron and microbial infection
Schaible, U. E., & Kaufmann, S. H. E. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1046 · Cited by 945
Self-citation
Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
Pai, M., Riley, L. W., & Colford, J. M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01206-x · Cited by 913
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
Barouch, D. H., Santra, S., Schmitz, J. E., Kuroda, M. J., Fu, T.-M., Wagner, W., Bilska, M., Craiu, A., Zheng, X. X., Krivulka, G. R., et al. (2000) · Science · doi:10.1126/science.290.5491.486 · Cited by 881
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon
Le Bon, A., Etchart, N., Rossmann, C., Ashton, M., Hou, S., Gewert, D., Borrow, P., & Tough, D. F. (2003) · Nature Immunology · doi:10.1038/ni978 · Cited by 818
HIV vaccine design and the neutralizing antibody problem
Burton, D. R., Desrosiers, R. C., Doms, R. W., Koff, W. C., Kwong, P. D., Moore, J. P., Nabel, G. J., Sodroski, J., Wilson, I. A., & Wyatt, R. T. (2004) · Nature Immunology · doi:10.1038/ni0304-233 · Cited by 765
Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
Cox, J. S., Chen, B., McNeil, M., & Jacobs, W. R. (1999) · Nature · doi:10.1038/47042 · Cited by 745
Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level
Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S., & Mallal, S. A. (2002) · Science · doi:10.1126/science.1069660 · Cited by 740
Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin
Sherman, D. R., Voskuil, M., Schnappinger, D., Liao, R., Harrell, M. I., & Schoolnik, G. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121172498 · Cited by 729
How can immunology contribute to the control of tuberculosis?
Kaufmann, S. H. E. (2001) · Nature Reviews Immunology · doi:10.1038/35095558 · Cited by 729
Self-citation
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
Barouch, D. H., Kunstman, J., Kuroda, M. J., Schmitz, J. E., Santra, S., Peyerl, F. W., Krivulka, G. R., Beaudry, K., Lifton, M. A., Gorgone, D. A., et al. (2002) · Nature · doi:10.1038/415335a · Cited by 661
CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection
Sun, J. C., Williams, M. A., & Bevan, M. J. (2004) · Nature Immunology · doi:10.1038/ni1105 · Cited by 649
Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
Pym, A. S., Brodin, P., Majlessi, L., Brosch, R., Demangel, C., Williams, A., Griffiths, K. E., Marchal, G., Leclerc, C., & Cole, S. T. (2003) · Nature Medicine · doi:10.1038/nm859 · Cited by 644
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
Schneider, J., Gilbert, S. C., Blanchard, T. J., Hanke, T., Robson, K. J., Hannan, C. M., Becker, M., Sinden, R., Smith, G. L., & Hill, A. V. S. (1998) · Nature Medicine · doi:10.1038/nm0498-397 · Cited by 644
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Randall Deck, R., DeWitt, C. M., Orme, I. M., Baldwin, S., D'Souza, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-893 · Cited by 629
The Challenge of Viral Reservoirs in HIV-1 Infection
Blankson, J. N., Persaud, D., & Siliciano, R. F. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104024 · Cited by 627
Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission
Derdeyn, C. A., Decker, J. M., Bibollet-Ruche, F., Mokili, J. L., Muldoon, M., Denham, S. A., Heil, M. L., Kasolo, F., Musonda, R., Hahn, B. H., et al. (2004) · Science · doi:10.1126/science.1093137 · Cited by 617
Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment
van Rie, A., Warren, R., Richardson, M., Victor, T. C., Gie, R. P., Enarson, D. A., Beyers, N., & van Helden, P. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411602 · Cited by 610
Worldwide Occurrence of Beijing/W Strains of Mycobacterium tuberculosis: A Systematic Review
Glynn, J. R., Whiteley, J., Bifani, P. J., Kremer, K., & van Soolingen, D. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0805.020002 · Cited by 577
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
McShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A., & Hill, A. V. S. (2004) · Nature Medicine · doi:10.1038/nm1128 · Cited by 570
Molecular determinants of Listeria monocytogenes pathogenesis
Portnoy, D. A., Chakraborty, T., Goebel, W., & Cossart, P. (1992) · Infection and Immunity · doi:10.1128/iai.60.4.1263-1267.1992 · Cited by 554
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
McConkey, S. J., Reece, W. H. H., Moorthy, V. S., Webster, D., Dunachie, S., Butcher, G., Vuola, J. M., Blanchard, T. J., Gothard, P., Watkins, K., et al. (2003) · Nature Medicine · doi:10.1038/nm881 · Cited by 553
Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains
Bifani, P. J., Mathema, B., Kurepina, N. E., & Kreiswirth, B. N. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02277-6 · Cited by 500
HIV and SIV CTL escape: implications for vaccine design
Goulder, P. J. R., & Watkins, D. I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1417 · Cited by 500
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*
Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., & Pau, A. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00001 · Cited by 482
Therapy of tuberculosis in mice by DNA vaccination
Lowrie, D. B., Tascon, R. E., Bonato, V. L. D., Lima, V. M. F., Faccioli, L. H., Stavropoulos, E., Colston, M. J., Hewinson, R. G., Moelling, K., & Silva, C. L. (1999) · Nature · doi:10.1038/22326 · Cited by 474
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
Pethe, K., Alonso, S., Biet, F., Delogu, G., Brennan, M. J., Locht, C., & Menozzi, F. D. (2001) · Nature · doi:10.1038/35084083 · Cited by 468
HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity
Younes, S.-A., Yassine-Diab, B., Dumont, A. R., Boulassel, M.-R., Grossman, Z., Routy, J.-P., & Sékaly, R.-P. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031598 · Cited by 460
Therapeutic dendritic-cell vaccine for chronic HIV-1 infection
Lu, W., Arraes, L. C., Ferreira, W. T., & Andrieu, J.-M. (2004) · Nature Medicine · doi:10.1038/nm1147 · Cited by 448
Genetics of susceptibitlity to human infectious disease
Cooke, G. S., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 444
Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
Horwitz, M. A., Harth, G., Dillon, B. J., & Masleša-Galić, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250480397 · Cited by 436
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
Rowland-Jones, S. L., Dong, T., Fowke, K. R., Kimani, J., Krausa, P., Newell, H., Blanchard, T., Ariyoshi, K., Oyugi, J., Ngugi, E., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4314 · Cited by 421
Self-citation
Adaptive Immune Response of Vγ2Vδ2 + T Cells During Mycobacterial Infections
Shen, Y., Zhou, D., Qiu, L., Lai, X., Simon, M., Shen, L., Kou, Z., Wang, Q., Jiang, L., Estep, J., et al. (2002) · Science · doi:10.1126/science.1068819 · Cited by 385
An essential role for phoP in Mycobacterium tuberculosis virulence
Pérez, E., Samper, S., Bordas, Y., Guilhot, C., Gicquel, B., & Martín, C. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02500.x · Cited by 379
Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells
Fischer, K., Scotet, E., Niemeyer, M., Koebernick, H., Zerrahn, J., Maillet, S., Hurwitz, R., Kursar, M., Bonneville, M., Kaufmann, S. H. E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403787101 · Cited by 378
Self-citation
Reversion of CTL escape–variant immunodeficiency viruses in vivo
Friedrich, T. C., Dodds, E. J., Yant, L. J., Vojnov, L., Rudersdorf, R., Cullen, C., Evans, D. T., Desrosiers, R. C., Mothé, B. R., Sidney, J., et al. (2004) · Nature Medicine · doi:10.1038/nm998 · Cited by 369
Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy
Ogg, G. S., Jin, X., Bonhoeffer, S., Moss, P., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Hurley, A., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.797-800.1999 · Cited by 348
Self-citation
Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6
Olsen, A. W., van Pinxteren, L. A. H., Okkels, L. M., Rasmussen, P. B., & Andersen, P. (2001) · Infection and Immunity · doi:10.1128/iai.69.5.2773-2778.2001 · Cited by 344
Human tuberculous granulomas induce peripheral lymphoid follicle‐like structures to orchestrate local host defence in the lung
Ulrichs, T., Kosmiadi, G. A., Trusov, V., Jörg, S., Pradl, L., Titukhina, M., Mishenko, V., Gushina, N., & Kaufmann, S. H. (2004) · The Journal of Pathology · doi:10.1002/path.1628 · Cited by 331
Self-citation
ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROL
McMichael, A. J., & Phillips, R. E. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.271 · Cited by 323
Self-citation
Differential Immune Responses and Protective Efficacy Induced by Components of a Tuberculosis Polyprotein Vaccine, Mtb72F, Delivered as Naked DNA or Recombinant Protein
Skeiky, Y. A. W., Alderson, M. R., Ovendale, P. J., Guderian, J. A., Brandt, L., Dillon, D. C., Campos-Neto, A., Lobet, Y., Dalemans, W., Orme, I. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7618 · Cited by 313
Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccines
Aldovini, A., & Young, R. A. (1991) · Nature · doi:10.1038/351479a0 · Cited by 313
HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus
Altfeld, M., Allen, T. M., Yu, X. G., Johnston, M. N., Agrawal, D., Korber, B. T., Montefiori, D. C., O'Connor, D. H., Davis, B. T., Lee, P. K., et al. (2002) · Nature · doi:10.1038/nature01200 · Cited by 304
gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?
Kaufmann, S. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2272 · Cited by 299
Self-citation
The BCG Story: Lessons from the Past and Implications for the Future
Fine, P. E. M. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_2.s353 · Cited by 295
CD8 + T Cell Cross-Priming via Transfer of Proteasome Substrates
Norbury, C. C., Basta, S., Donohue, K. B., Tscharke, D. C., Princiotta, M. F., Berglund, P., Gibbs, J., Bennink, J. R., & Yewdell, J. W. (2004) · Science · doi:10.1126/science.1096378 · Cited by 286
Tuberculosis and the Tubercle Bacillus
(2004) · Wiley eBooks · doi:10.1128/9781555817657 · Cited by 270
Mycobacterium bovis BCG Response Regulator Essential for Hypoxic Dormancy
Boon, C., & Dick, T. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.24.6760-6767.2002 · Cited by 251
Characterization of Auxotrophic Mutants of Mycobacterium tuberculosis and Their Potential as Vaccine Candidates
Smith, D. A., Parish, T., Stoker, N. G., & Bancroft, G. J. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.1442-1150.2001 · Cited by 243
Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases
Cooper, R. N., Kremer, M. R., & Glennerster, R. (2005) · Foreign Affairs · doi:10.2307/20034297 · Cited by 237
In interleukin‐4‐deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production
Brewer, J. M., Conacher, M., Satoskar, A., Bluethmann, H., & Alexander, J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260915 · Cited by 232
Enhanced Immunogenicity of CD4+T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis
McShane, H., Brookes, R., Gilbert, S. C., & Hill, A. V. S. (2001) · Infection and Immunity · doi:10.1128/iai.69.2.681-686.2001 · Cited by 231
Is the development of a new tuberculosis vaccine possible?
Kaufmann, S. H. E. (2000) · Nature Medicine · doi:10.1038/79631 · Cited by 225
Self-citation
Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses
Kaul, R., Rowland-Jones, S. L., Kimani, J., Dong, T., Yang, H.-B., Kiama, P., Rostron, T., Njagi, E., Bwayo, J. J., MacDonald, K. S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10714 · Cited by 223
Self-citation
Microparticles as vaccine adjuvants and delivery systems
O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.269 · Cited by 214
HIV-1/AIDS and the control of other infectious diseases in Africa
Corbett, E. L., Steketee, R. W., ter Kuile, F. O., Latif, A. S., Kamali, A., & Hayes, R. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09095-5 · Cited by 212
Mycobacterium bovis bacille Calmette–Guérin strains secreting listeriolysin of Listeria monocytogenes
Hess, J., Miko, D., Catic, A., Lehmensiek, V., Russell, D. G., & Kaufmann, S. H. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5299 · Cited by 197
Self-citation
Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis
Hingley-Wilson, S. M., Sambandamurthy, V. K., & Jacobs, W. R. (2003) · Nature Immunology · doi:10.1038/ni981 · Cited by 192
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
Hel, Z., Venzon, D., Poudyal, M., Tsai, W.-P., Giuliani, L., Woodward, R., Chougnet, C., Shearer, G., Altman, J. D., Watkins, D., et al. (2000) · Nature Medicine · doi:10.1038/80481 · Cited by 187
Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines.
Murray, P. J., Aldovini, A., & Young, R. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.934 · Cited by 185
Antigen Bias in T Cell Cross-Priming
Wolkers, M. C., Brouwenstijn, N., Bakker, A. H., Toebes, M., & Schumacher, T. N. M. (2004) · Science · doi:10.1126/science.1096268 · Cited by 181
The immunological aspects of latency in tuberculosis
Chan, J., & Flynn, J. (2004) · Clinical Immunology · doi:10.1016/s1521-6616(03)00210-9 · Cited by 178
The Protective Effect of the Mycobacterium bovis BCG Vaccine Is Increased by Coadministration with the Mycobacterium tuberculosis 72-Kilodalton Fusion Polyprotein Mtb72F in M. tuberculosis -Infected Guinea Pigs
Brandt, L., Skeiky, Y. A. W., Alderson, M. R., Lobet, Y., Dalemans, W., Turner, O. C., Basaraba, R. J., Izzo, A. A., Lasco, T. M., Chapman, P. L., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6622-6632.2004 · Cited by 174
HIV-1 dynamics in vivo: implications for therapy
Simon, V., & Ho, D. D. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro772 · Cited by 170
Auxotrophic vaccines for tuberculosis
Guleria, I., Teitelbaum, R., McAdam, R. A., Kalpana, G., Jacobs, W. R., & Bloom, B. R. (1996) · Nature Medicine · doi:10.1038/nm0396-334 · Cited by 166
T Cell Cross-Reactivity and Conformational Changes during TCR Engagement
Lee, J. K., Stewart-Jones, G., Dong, T., Harlos, K., Di Gleria, K., Dorrell, L., Douek, D. C., van der Merwe, P. A., Jones, E. Y., & McMichael, A. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041251 · Cited by 161
Self-citation
Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin
Temmerman, S. T., Pethe, K., Parra, M., Alonso, S., Rouanet, C., Pickett, T. E., Drowart, A., Debrie, A., Delogu, G., Menozzi, F. D., et al. (2004) · Nature Medicine · doi:10.1038/nm1090 · Cited by 147
Tuberculosis and the Tubercle Bacillus
Liu, J. (2005) · Emerging infectious diseases · doi:10.3201/eid1108.050611 · Cited by 141
CD8+ T Cells in Tuberculosis
Lazarevic, V., & Flynn, J. L. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2204027 · Cited by 129
New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development
Kamath, A. T., Fruth, U., Brennan, M. J., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.03.001 · Cited by 120
Vaccination of Macaques with Long-Standing SIVmac251 Infection Lowers the Viral Set Point After Cessation of Antiretroviral Therapy
Tryniszewska, E. A., Nacsa, J., Lewis, M. G., Silvera, P. M., Montefiori, D. C., Venzon, D. J., Hel, Z., Parks, R. W., Moniuszko, M., Tartaglia, J., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5347 · Cited by 91
HIV vaccine strategies
Nabel, G. J. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00074-9 · Cited by 72
Safety and Immune Responses to a DNA‐Based Human Immunodeficiency Virus (HIV) Type I Env/Rev Vaccine in HIV‐Infected Recipients: Follow‐up Data
MacGregor, R. R., Boyer, J., Ciccarelli, R. B., Ginsberg, R. S., & WEINER, D. B. (2000) · The Journal of Infectious Diseases · doi:10.1086/315199 · Cited by 71
Vaccine developments
Liu, M. A. (1998) · Nature Medicine · doi:10.1038/nm0598supp-515 · Cited by 70
Recombinant bacille Calmette–Guérin (BCG) expressing human interferon-alpha 2B demonstrates enhanced immunogenicity
Luo, Y., Chen, X., Han, R., & O’Donnell, M. A. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01428.x · Cited by 60
Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus
Stebbings, R., Almond, N. M., Stott, E. J., Berry, N. J., Wade‐Evans, A., Hull, R., Lines, J. L., Silvera, P. M., Sangster, R., Corcoran, T., et al. (2002) · Virology · doi:10.1006/viro.2002.1379 · Cited by 59
Type I interferons promote cross-priming: more functions for old cytokines
Beignon, A., Škoberne, M., & Bhardwaj, N. (2003) · Nature Immunology · doi:10.1038/ni1003-939 · Cited by 53
Identification ofMycobacterium tuberculosisCounterimmune (cim) Mutants in Immunodeficient Mice by Differential Screening
Hisert, K. B., Kirksey, M., Gomez, J. E., Sousa, A. O., Cox, J. S., Jacobs, W. R., Nathan, C., & McKinney, J. D. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5315-5321.2004 · Cited by 50
Improved protection by recombinant BCG
Eddine, A. N., & Kaufmann, S. H. E. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.012 · Cited by 39
Self-citation
Reduced Functional Capacity of CD8+ T Cells Expanded by Post-Exposure Vaccination of γ-Herpesvirus-Infected CD4-Deficient Mice
Liu, H., Andreansky, S. S., Diaz, G. M., Hogg, T. L., & Doherty, P. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3477 · Cited by 38
A Waxy Tale, byMycobacterium tuberculosis
Kremer, L., & Besra, G. S. (2004) · Wiley eBooks · doi:10.1128/9781555817657.ch19 · Cited by 22
HLA class I serotypes and cytotoxic T‐lymphocyte responses among human immunodeficiency virus‐1‐uninfected Thai volunteers immunized with ALVAC‐HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting
Paris, R., Bejrachandra, S., Karnasuta, C., Chandanayingyong, D., Kunachiwa, W., Leetrakool, N., Prakalapakorn, S. G., D, P. T. M., Nitayaphan, S., Pitisuttithum, P., et al. (2004) · Tissue Antigens · doi:10.1111/j.1399-0039.2004.00270.x · Cited by 20
CD8 T Cells in Tuberculosis
Kaufmann, S. H. E., & Flynn, J. L. (2004) · doi:10.1128/9781555817657.ch29 · Cited by 16
Self-citation
Mycobacterium tuberculosis : the Indigestible Microbe
Russell, D. G. (2004) · Wiley eBooks · doi:10.1128/9781555817657.ch26 · Cited by 10
CD1 and Tuberculosis
Dascher, C. C., & Brenner, M. B. (2004) · Wiley eBooks · doi:10.1128/9781555817657.ch30 · Cited by 4
Intracellular Models of Mycobacterium tuberculosis Infection
Chan, J., Silver, R. F., Kampmann, B., & Wallis, R. S. (2004) · Wiley eBooks · doi:10.1128/9781555817657.ch27 · Cited by 2

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Viral infection and iron metabolism
Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469
Apoptotic Vesicles Crossprime CD8 T Cells and Protect against Tuberculosis
Winau, F., Weber, S., Sad, S., de Diego, J., Hoops, S. L., Breiden, B., Sandhoff, K., Brinkmann, V., Kaufmann, S. H. E., & Schaible, U. E. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.001 · Cited by 395
Self-citation
New vaccines for tuberculosis
Kaufmann, S. H., Hussey, G., & Lambert, P.-H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60393-5 · Cited by 299
Self-citation
Cutting Edge: Regulatory T Cells Prevent Efficient Clearance of Mycobacterium tuberculosis
Kursar, M., Koch, M., Mittrücker, H.-W., Nouailles, G., Bonhagen, K., Kamradt, T., & Kaufmann, S. H. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2661 · Cited by 290
Self-citation

See all 273

Authors: Kaufmann, S. H. E., & McMichael, A. J.
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 2005-04
Volume: 11
Issue: S4
Pages: S33-S44
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/nm1221
OpenAlex: W1984009950
Cited by: 273
References: 105
FWCI: 17.41
Type: journal article
Language: en
Open access: bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources